Structural

Keynote Lecture: Are New Generation TMVR Systems Addressing the Clinical and Anatomical Needs?

13 min.

TMVR Will Rely on the Evolution of Imaging: Current Trends and Future Possibilities

7 min.

It's All About the LVOT: Septal and Leaflet Modification; Other Emerging TMVR Device Solutions

12 min.

It's All About Anchoring: TMVR Design and Performance

12 min.

Transeptal TMVR – Have Technology Developments Met Clinical Expectations?

14 min.

Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes?

13 min.

Lessons Learned from Imaging Screening in TMVR Trials

14 min.

Lessons Learned in TMVR Trial Design, Patient Selection, and Indications

17 min.

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

14 min.

Surgery Following Transcatheter Mitral Procedures: Outcomes and Perspectives

11 min.

TMVR Following Failed M-TEER: Technical and Procedural Considerations

12 min.

Pro-Surgery

13 min.

Pro-TMVR

4 min.

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

14 min.

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

16 min.

PRO: TMVR Is a Good Option for Functional MR

5 min.

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

9 min.

CON: TMVR Has too Many Problems – Just Do M-TEER

15 min.

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

17 min.

EVOQUE System and the TMTT Portfolio

20 min.

Beyond MAC: Paths Forward for Mitral Valve Therapies – How Can Technology Address the Clinical Need

22 min.

Screening for Transcatheter Native Mitral Valve Intervention: Multimodality Imaging

13 min.

Atrial FMR: The Structuralist Perspective – Transcatheter Therapies

15 min.

Direct THV Implantation in MAC

22 min.

Transcatheter Mitral Valve Replacement Devices: Highlife

11 min.

TMVR for Calcific MS/MR: The Definitive Solution?

14 min.

What Design Features Are Must-Haves for TMVR to Become Mainstream?

19 min.

How Can We Solve the TMVR High Screen Failure Rate?

7 min.

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

16 min.

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

5 min.

New TMVR Devices:Cardiovalve

4 min.

New TMVR Devices: Altavalve.

11 min.

New TMVR Devices: Highlife.

4 min.

New TMVR Devices: Evoque Eos Update and Learnings

4 min.

New TMVR Devices: Cephea.

5 min.

New TMVR Devices: M3.

7 min.

New TMVR Devices: Intrepid

4 min.

New TMVR Devices: Tendyne

4 min.

Tendyne TMVR SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

17 min.

Transcatheter Mitral Valve Replacement Devices: Innovalve

7 min.

Transcatheter Mitral Valve Replacement Devices: AltaValve

7 min.

Transcatheter Mitral Valve Replacement Devices: Cephea

8 min.

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

7 min.

TMVR Design Iteration and Patient Eligibility

17 min.

The Transcatheter Edge-to-Edge Repair Procedure: Tips and Tricks

14 min.

What Devices Are Available? Introduction to Device Controls

5 min.

Atrial and Ventricular Functional MR: Treatment Implications

9 min.

Innovalve TMVR A new transcatheter mitral valve replacement system

10 min.

M3 Trial (Encircle)

5 min.

Are TMVR Devices Designed to Meet the Tricuspid Needs? – Technological Challenges and Opportunities for Innovation

8 min.

Next Generation TMVR Devices: A Step Forward in Patient Selection and Eligibility?

18 min.

Cephea

5 min.

Highlife

5 min.

AltaValve

7 min.

Featured TAVR Innovation: Treatment of Infective Endocarditis (IE) Using Drug-Eluting Transcatheter Valve Replacement (DE - TAVR)

7 min.

Interventional Perspectives and Emerging Therapeutic Options

6 min.

ENCIRCLE Trial (M3)

5 min.

APOLLO Trial (Intrepid)

5 min.

SUMMIT Trial (Tendyne)

5 min.

TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0?

6 min.

Intrepid – APOLLO MAC Cohort

2 min.

Tendyne – SUMMIT MAC Cohort

3 min.

Transfemoral Sapien in MAC

5 min.

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

5 min.

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

6 min.

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

6 min.

The Opus VR Valve: A Novel TMVR Tethered to the Ventricular Septum (Opus Medical)

3 min.

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

5 min.

Choice of Optimal Transcatheter Treatment for Mitral Insufficiency: 2-Year Real-World Outcomes in the CHOICE MI International Registry

6 min.